Marico Ltd’s stock dropped nearly 5 percent on Tuesday due to political unrest in Bangladesh, a key market for the company. Bangladesh contributes approximately 11 percent of Marico’s consolidated business.
During trading, Marico’s shares were priced around Rs 640 each, marking a decline of 4.9 percent. In the last fiscal year (FY24), Marico Bangladesh Ltd reported revenue of Rs 1,103 crore, representing 11 percent of Marico’s total consolidated revenue. For its international operations, Bangladesh accounts for about 44 percent of the total revenue.
Despite the recent dip in stock price, Marico’s net profit for the April-June quarter increased by 8.7 percent year-on-year, reaching Rs 474 crore. Over the past 12 months, Marico’s shares have risen by 12.89 percent and are up 17.78 percent year-to-date (YTD).
Also Read:Indian Stock Market Shows Resilience Amid US Economic Slowdown
In its quarterly report, Marico stated its goal to reduce the revenue contribution from Bangladesh to less than 40 percent by the end of fiscal year 2027. For Q1 FY25, Bangladesh achieved a 10 percent constant currency growth (CCG), demonstrating resilience and sustained business momentum.
Marico highlighted its international business performance, noting growth despite macroeconomic challenges and currency devaluations in certain regions. The company reported strong growth in markets such as the Middle East, North Africa (MENA), and South Africa, which has helped diversify its international revenue base.
Ahead of Diwali, Prime Minister Narendra Modi urged the public to celebrate the festival by…
Uttar Pradesh CM Yogi Adityanath announced that 1.51 crore lamps were lit across the state,…
Leaders and diplomatic missions from the UAE, Singapore, and Iran extended warm Diwali wishes to…
The Press Information Bureau (PIB) has declared as false a viral WhatsApp message claiming government…
Prez Murmu and Vice President CP Radhakrishnan have wished citizens a happy Diwali, urging everyone…
Obesity, not metabolic syndrome, is linked to higher Alzheimer’s risk in adults with Down syndrome,…